Metals in Alzheimer's and Parkinson's diseases.

There has been steadily growing interest in the participation of metal ions (especially, zinc, copper, and iron) in neurobiological processes, such as the regulation of synaptic transmission. Recent descriptions of the release of zinc and copper in the cortical glutamatergic synapse, and influencing the response of the NMDA receptor underscore the relevance of understanding the inorganic milieu of the synapse to neuroscience. Additionally, major neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease, are characterized by elevated tissue iron, and miscompartmentalization of copper and zinc (e.g. accumulation in amyloid). Increasingly sophisticated medicinal chemistry approaches, which correct these metal abnormalities without causing systemic disturbance of these essential minerals, are being tested. These small molecules show promise of being disease-modifying.

[1]  R. Tanzi,et al.  Modulation of A beta adhesiveness and secretase site cleavage by zinc. , 1994, The Journal of biological chemistry.

[2]  J. Troncoso,et al.  Immersion autometallographic tracing of zinc ions in Alzheimer beta-amyloid plaques , 2005, Histochemistry and Cell Biology.

[3]  P. Pasqualetti,et al.  Excess of serum copper not related to ceruloplasmin in Alzheimer disease , 2005, Neurology.

[4]  Yaping Zeng,et al.  Synaptic release of zinc from brain slices: Factors governing release, imaging, and accurate calculation of concentration , 2006, Journal of Neuroscience Methods.

[5]  D. Birchall,et al.  Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. , 2006, Brain : a journal of neurology.

[6]  Xudong Huang,et al.  Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). , 2002, The Journal of biological chemistry.

[7]  A. Craig,et al.  NMDA Receptor Activation Mediates Copper Homeostasis in Hippocampal Neurons , 2005, The Journal of Neuroscience.

[8]  A. Loguinov,et al.  Gene expression profiling in chronic copper overload reveals upregulation of Prnp and App. , 2004, Physiological genomics.

[9]  J. Jankovic,et al.  Prevention and restoration of lactacystin‐induced nigrostriatal dopamine neuron degeneration by novel brain‐permeable iron chelators , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  A. Mehta,et al.  Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity , 2007, Proceedings of the National Academy of Sciences.

[11]  R. Mains,et al.  Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease , 2007, Neurobiology of Disease.

[12]  R. Cappai,et al.  Molecular determinants of Alzheimer’s disease Aβ peptide neurotoxicity , 2007 .

[13]  Joseph A. Helpern,et al.  Histological Co-Localization of Iron in Aß Plaques of PS/APP Transgenic Mice , 2005, Neurochemical Research.

[14]  Michael W Parker,et al.  Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions. , 2007, Journal of molecular biology.

[15]  G. Bartzokis,et al.  MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. , 2000, Cellular and molecular biology.

[16]  M. Youdim,et al.  Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases , 2005, Mechanisms of Ageing and Development.

[17]  R. Palmiter,et al.  Estrogen Decreases Zinc Transporter 3 Expression and Synaptic Vesicle Zinc Levels in Mouse Brain* , 2004, Journal of Biological Chemistry.

[18]  William M. Mauck,et al.  Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice , 2004, Journal of neurochemistry.

[19]  Antonio Lanzirotti,et al.  Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. , 2006, Journal of structural biology.

[20]  D. Sparks,et al.  Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology. , 2006, The journal of nutrition, health & aging.

[21]  Yi Ai,et al.  Correlation of R2 with total iron concentration in the brains of rhesus monkeys , 2005, Journal of magnetic resonance imaging : JMRI.

[22]  V. Haroutunian,et al.  Elevated cortical zinc in Alzheimer disease , 2006, Neurology.

[23]  R. Mains,et al.  ATP7A (Menkes protein) functions in axonal targeting and synaptogenesis , 2007, Molecular and Cellular Neuroscience.

[24]  C. Angelini,et al.  Exploring mental status in Friedreich's ataxia: a combined neuropsychological, behavioral and neuroimaging study , 2006, European journal of neurology.

[25]  Khadija Iqbal,et al.  Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia , 2004, Acta Neuropathologica.

[26]  R. Nussbaum,et al.  Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments. , 2005, The Journal of biological chemistry.

[27]  M. Youdim,et al.  Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson’s disease and other neurodegenerative diseases , 2004, Journal of Neural Transmission.

[28]  T. Masumizu,et al.  Growth Inhibitory Factor Prevents Neurite Extension and the Death of Cortical Neurons Caused by High Oxygen Exposure through Hydroxyl Radical Scavenging* , 2002, The Journal of Biological Chemistry.

[29]  Colin L Masters,et al.  Gene knockout of amyloid precursor protein and amyloid precursor‐like protein‐2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts , 2004, Journal of neurochemistry.

[30]  Xudong Huang,et al.  Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta. , 2004, Biochemistry.

[31]  M. Stoltenberg,et al.  Zinc-specific Autometallographic In Vivo Selenium Methods: Tracing of Zinc-enriched (ZEN) Terminals, ZEN Pathways, and Pools of Zinc Ions in a Multitude of Other ZEN Cells , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  M. Stoltenberg,et al.  Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency , 2007, Neuroscience.

[33]  P. Bauer,et al.  Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease , 2004, Neurology.

[34]  S. Melov,et al.  Alzheimer disease β-amyloid activity mimics cholesterol oxidase , 2005 .

[35]  V. Uversky,et al.  Certain Metals Trigger Fibrillation of Methionine-oxidized α-Synuclein* , 2003, Journal of Biological Chemistry.

[36]  C. Quintana,et al.  Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. , 2006, Journal of structural biology.

[37]  L. Mucke,et al.  Reduction in Mitochondrial Superoxide Dismutase Modulates Alzheimer's Disease-Like Pathology and Accelerates the Onset of Behavioral Changes in Human Amyloid Precursor Protein Transgenic Mice , 2006, The Journal of Neuroscience.

[38]  R. Cherny,et al.  Dimerisation of N-acetyl-l-tyrosine ethyl ester and Aβ peptides via formation of dityrosine , 2006, Free radical research.

[39]  D. Sparks,et al.  Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Leonidas Stefanis,et al.  α-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis , 2006, The Journal of Neuroscience.

[41]  T. Bayer,et al.  Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Bush,et al.  Metals and neuroscience. , 2000, Current opinion in chemical biology.

[43]  C. Masters,et al.  Methionine regulates copper/hydrogen peroxide oxidation products of Aβ , 2005, Journal of peptide science : an official publication of the European Peptide Society.

[44]  S. Maiti,et al.  Selective destabilization of soluble amyloid β oligomers by divalent metal ions , 2006 .

[45]  Xudong Huang,et al.  An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript* , 2002, The Journal of Biological Chemistry.

[46]  Marc Dhenain,et al.  Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease , 2006, Neurobiology of Disease.

[47]  K. Freeman,et al.  BACE1 Cytoplasmic Domain Interacts with the Copper Chaperone for Superoxide Dismutase-1 and Binds Copper* , 2005, Journal of Biological Chemistry.

[48]  Clifford R Jack,et al.  In Vivo Magnetic Resonance Microimaging of Individual Amyloid Plaques in Alzheimer's Transgenic Mice , 2005, The Journal of Neuroscience.

[49]  J. Schneider,et al.  Dietary copper and high saturated and trans fat intakes associated with cognitive decline. , 2006, Archives of neurology.

[50]  G. Multhaup,et al.  Copper Depletion Down-regulates Expression of the Alzheimer's Disease Amyloid-β Precursor Protein Gene* , 2004, Journal of Biological Chemistry.

[51]  Jean-Marc Burgunder,et al.  Novel mutation in the ceruloplasmin gene causing a cognitive and movement disorder with diabetes mellitus , 2006, Movement disorders : official journal of the Movement Disorder Society.

[52]  D. Westaway,et al.  In vivo reduction of amyloid-β by a mutant copper transporter , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Palmiter,et al.  Neuronal Zinc Exchange with the Blood Vessel Wall Promotes Cerebral Amyloid Angiopathy in an Animal Model of Alzheimer's Disease , 2004, The Journal of Neuroscience.

[54]  D. Berg,et al.  Disturbance of iron metabolism in Parkinson’s disease — ultrasonography as a biomarker , 2009, Neurotoxicity Research.

[55]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[56]  Tetsuya Suhara,et al.  Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography , 2007, The Journal of Neuroscience.

[57]  D. Metodiewa.  Molecular mechanisms of cellular injury produced by neurotoxic amino acids that generate reactive oxygen species , 2005, Amino Acids.

[58]  A. Bush,et al.  The neurobiology of zinc in health and disease , 2005, Nature Reviews Neuroscience.

[59]  C. Masters,et al.  In vitro gamma‐secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc , 2005, The FEBS journal.

[60]  M. Youdim,et al.  M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson's disease. , 2006, Journal of neural transmission. Supplementum.

[61]  P. Boyer,et al.  Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology , 2007, Proceedings of the National Academy of Sciences.

[62]  D. Butterfield,et al.  Oxidative Stress in Alzheimer's Disease Brain: New Insights from Redox Proteomics , 2006 .

[63]  D. Holtzman,et al.  Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity , 2006, Proceedings of the National Academy of Sciences.

[64]  R. Moreau,et al.  Dietary supplementation with (R)-α-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex , 2005, Redox report : communications in free radical research.

[65]  A. Bush,et al.  Metals and Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[66]  Jae-Young Koh,et al.  Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[67]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[68]  Subramanian Rajagopalan,et al.  Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo A Novel Therapy for Parkinson's Disease , 2003, Neuron.

[69]  George Perry,et al.  Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. , 2003, Biochemistry.

[70]  K. Blennow,et al.  Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid , 2009, Neurobiology of Aging.

[71]  C. Masters,et al.  Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β‐amyloid , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  M. Kazachkov,et al.  Effect of aldehydes derived from oxidative deamination and oxidative stress on β-amyloid aggregation; pathological implications to Alzheimer’s disease , 2007, Journal of Neural Transmission.

[73]  C. Masters,et al.  Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau , 2007, PloS one.

[74]  R. Krüger,et al.  The FASEB Journal express article 10.1096/fj.04-3486fje. Published online September 8, 2005. Functional relevance of ceruloplasmin mutations in Parkinson’s Disease , 2022 .